Research Article
Sequence Variants of Peroxisome Proliferator-Activated Receptor-Gamma Gene and the Clinical Courses of Patients with End-Stage Renal Disease
Table 2
Characteristics of the study population by case and control status.
| Variables | Controls | Cases | |
| Number of subjects | 782 | 698 | | Age (years) | 60.0 ± 19.2 | 58.8 ± 14.6 | <0.001 | Male | 412 (52.2%) | 334 (44.8%) | 0.068 | DM | 83 (10.6%) | 263 (37.7%) | <0.001 | Serum creatinine (mg/dL) | 1.0 ± 0.3 | 11.2 ± 2.5 | <0.001 | Serum albumin (g/dL) | 4.4 ± 0.2 | 3.9 ± 0.5 | <0.001 | PPAR-γ Pro12Ala genotype | | | 0.037 | CC | 735 (94.0%) | 635 (91.1%) | | CG | 46 (5.9%) | 58 (8.2%) | | GG | 1 (0.1%) | 5 (0.7%) | | PPAR-γ C161T genotype | | | 0.482 | CC | 451 (57.7%) | 384 (55.0%) | | CT | 283 (36.2%) | 263 (37.7%) | | TT | 48 (6.1%) | 51 (7.3%) | | Death | 39 (5.0%) | 217 (31.1%) | <0.001 |
|
|
*Continuous variables were tested by Mann-Whitney tests, whereas categorical variables were tested by Fisher’s exact test.
|